Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 1 June 2004
Vol. 2004, Issue 235, p. tw195
[DOI: 10.1126/stke.2352004TW195]

EDITORS' CHOICE

IMMUNOLOGY Setting Dendritic Cell Life-Span

Dendritic cells are stimulated by various ligands derived from foreign cells, detecting infection, and by ligands expressed by T cells. Hou and Parijs reported that exposure of immature dendritic cells in culture to either Toll-like receptor (TLR) ligands--lipoteichoic acid (LTA), which binds TLR2; lipopolysaccharide (LPS), which binds TLR; or cytosine-phosphate-guanine (CpG), which binds TLR9--or to T cell costimulatory molecules CD40 ligand (CD40L) or TRANCE (tumor necrosis factor-related activation-induced cytokine) increased short-term cell survival. The abundance of the antiapoptotic protein Bcl-XL was increased in response to each of these ligands and was required for the increased short-term viability of the cells (1 to 3 days). CpG also produced an increase in the antiapoptotic protein Bcl-2 that persisted throughout the time period (1 to 4 days). At longer time periods (past 3 days), cells exposed to LPS or LTA exhibited decreased viability, an increase in the abundance of the proapoptotic protein Bim, and a decrease in Bcl-2. Exposure to CpG did not result in decreased Bcl-2, and exposure to CD40L did not alter the abundance of either Bcl-2 or Bim. Thus, the balance of Bim and Bcl-2 may contribute to differences in the ability of the ligands to prolong the life-span of dendritic cells. In vitro, cells deficient in Bcl-2 activated T cells; however, in vivo, Bcl-2-deficient dendritic cells did not produce T cell responses that were as robust as those observed with wild-type dendritic cells. In addition, the abundance of Bcl-2-deficient dendritic cells in the spleen and lymph nodes was lower than that observed for wild-type dendritic cells. Finally, mice with Bcl-2-deficient dendritic cells showed an increase in spleen and lymph node dendritic cells when exposed to CD40-specific antibodies, but a decrease in lymphoid-associated dendritic cells when exposed to LPS. Thus, different dendritic cell-activating ligands appear to activate different pathways that govern the life-span of these cells (see Moser).

W.-S. Hou, L. V. Parijs, A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat. Immunol. 5, 583-589 (2004). [Online Journal]

M. Moser, Balancing life and death. Nat. Immunol. 5, 559-560 (2004). [Online Journal]

Citation: Setting Dendritic Cell Life-Span. Sci. STKE 2004, tw195 (2004).


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882